|Articles|October 1, 1997

Profit warning pummels Lunar's stock

Shares of bone densitometry vendor Lunar plunged on Sept. 22 after the Madison, WI, company announced that it expected to post flat revenues and lower profits for its first fiscal quarter (end-September). The results were due to lower-than-expected

Shares of bone densitometry vendor Lunar plunged on Sept. 22 after the Madison, WI, company announced that it expected to post flat revenues and lower profits for its first fiscal quarter (end-September). The results were due to lower-than-expected densitometry sales in Japan and in the U.S., where many physicians have been confused about proposed reductions in the Medicare reimbursement rate for bone densitometry, according to the company. Lunar's stock dropped $4.56 a share, or 19%, to close at $19.44 on Sept. 22, the first day of trading after the news was announced.

In other Lunar news, the company in early September began shipping Pixi, its compact dual-energy x-ray absorptiometry (DEXA) densitometer. Pixi is targeted at the physician-office market and carries a list price of $32,000. Lunar shipped the first Pixi unit to a physician in the Washington, DC, area, according to the company.


Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.